Madhup Rastogi

Dr. Madhup Rastogi

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
SNSambit Swarup Nanda
Sambit Swarup Nanda
AGAjeet Kumar Gandhi
Ajeet Kumar Gandhi
MRMadhup Rastogi
Madhup Rastogi
RKRohini Khurana
Rohini Khurana
RHRahat Hadi
Rahat Hadi
DPDevendra Parmar
Devendra Parmar

17 September 2020 in Indian Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
VSVikas Sharma
Vikas Sharma
SPSandhya Pandey
Sandhya Pandey
AGAjeet Kumar Gandhi
Ajeet Kumar Gandhi
APArun Pandey
Arun Pandey
MRMadhup Rastogi
Madhup Rastogi
NHNuzhat Hussain
Nuzhat Hussain

1 December 2017 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
MRMadhup Rastogi
Madhup Rastogi
SNSambit Swarup Nanda
Sambit Swarup Nanda
AGAjeet Kumar Gandhi
Ajeet Kumar Gandhi
DDDivakar Dalela
Divakar Dalela
RKRohini Khurana
Rohini Khurana
NHNuzhat Husain
Nuzhat Husain
We compared the prostate motion variability and toxicities between patients treated with gold marker registration based IG-IMRT (IG-IMRT-M) and bony landmark registration based IG-IMRT (IG-IMRT-B). T1c-T3b (node negative), intermediate and high risk (non-metastatic) adenocarcinoma of prostate, age ≥18years, Karnofsky Performance Status of ≥70 were included in this retrospective study. The prostate motion variability, acute and late radiation toxicities between the two treatment arms (IG-IMRT-M versus IG-IMRT-B) were compared. Total of 35 patients (17 for IG-IMRT-M and 18 for IG-IMRT-B) were treated with a median radiotherapy dose of 76 Gray. The prostate variability observed with and without markers in millimeter was 4.1±2.3 vs 3.7±2.1 [Antero-Posterior (A-P); p=0.001], 2.3±1.5 vs 2.1±1.2 [Superior-Inferior (S-I); p=0.095] and 1.1±1.7 vs 0.4±1.4 [Left-Right (L-R); p=0.003]. There was higher acute toxicity in IG-IMRT-B arm compared to IG-IMRT-M arm in terms of grade ≥2 diarrhea [50% vs 11% OR=7.5 (1.3-42.7); p=0.02] and grade ≥2 proctitis [38% vs 5.8%, OR=10.1 (1.09-94.1); p=0.04]. At a median follow up of 36months, the late genitourinary toxicities grade ≥2 [27% vs 0%; p=0.04] were higher in the IG-IMRT-B arm compared to IG-IMRT-M arm. IG-IMRT-M detects higher prostate motion variability as compared to IG-IMRT-B, inferring a significant prostate motion inside fixed pelvic bony cavity. The addition of marker based image guidance results in higher precision of prostate localization and lesser acute and late toxicities.

1 September 2019 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Open access
MRMadhup Rastogi
Madhup Rastogi
AGAjeet K Gandhi
Ajeet K Gandhi
BDBharat Dua
Bharat Dua
KCKundan S Chufal
Kundan S Chufal
MSMadhu Srivastava
Madhu Srivastava
MBMadanlal B Bhatt
Madanlal B Bhatt
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.

1 November 2020 in Indian Journal of Medical Research
Verified
Journal Article
Open access
PDF file
MRMadhup Rastogi
Madhup Rastogi
AGAjeet Kumar Gandhi
Ajeet Kumar Gandhi
Indian J Med Res, Official publication of Indian Council of Medical Research,India

1 March 2019
Verified
Closed access
PDF file
HSHarikesh Bahadur Singh
Harikesh Bahadur Singh
AGAjeet Kumar Gandhi
Ajeet Kumar Gandhi
SSShantanu Sapru
Shantanu Sapru
RKRohini Khurana
Rohini Khurana
RHRahat Hadi
Rahat Hadi
MRMadhup Rastogi
Madhup Rastogi